Drug General Information
Drug ID
D04HXU
Former ID
DIB018612
Drug Name
4,9-anhydro-tetrodotoxin
Synonyms
4,9-anhydro-TTX; 4,9-ah-TTX
Drug Type
Small molecular drug
Indication Discovery agent Investigative [541065]
Structure
Download
2D MOL
Formula
C11H16N3O7+
InChI
InChI=1S/C11H15N3O7/c12-8-13-6-2-4-9(17,1-15)5-3(16)10(2,14-8)7(19-6)11(18,20-4)21-5/h2-7,15-18H,1H2,(H3,12,13,14)/p+1
InChIKey
STNXQECXKDMLJK-UHFFFAOYSA-O
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) SCN8A sodium channel subunit Target Info Blocker (channel blocker) [528857]
Reactome Interaction between L1 and Ankyrins
References
Ref 541065(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5730).
Ref 528857The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel. Am J Physiol Cell Physiol. 2007 Aug;293(2):C783-9. Epub 2007 May 23.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.